Advisor Group Holdings, Inc. Inmune Bio, Inc. Transaction History
Advisor Group Holdings, Inc.
- $44.4 Billion
- Q2 2025
A detailed history of Advisor Group Holdings, Inc. transactions in Inmune Bio, Inc. stock. As of the latest transaction made, Advisor Group Holdings, Inc. holds 2,850 shares of INMB stock, worth $6,897. This represents 0.0% of its overall portfolio holdings.
Number of Shares
2,850
Previous 13,925
79.53%
Holding current value
$6,897
Previous $108,000
94.44%
% of portfolio
0.0%
Previous 0.0%
Shares
21 transactions
Others Institutions Holding INMB
# of Institutions
102Shares Held
6.32MCall Options Held
1.64MPut Options Held
3.35M-
Vanguard Group Inc Valley Forge, PA848KShares$2.05 Million0.0% of portfolio
-
Black Rock Inc. New York, NY813KShares$1.97 Million0.0% of portfolio
-
Cvi Holdings, LLC Wilmington, DE596KShares$1.44 Million45.87% of portfolio
-
Ubs Group Ag449KShares$1.09 Million0.0% of portfolio
-
Geode Capital Management, LLC Boston, MA390KShares$943,6330.0% of portfolio
About Inmune Bio, Inc.
- Ticker INMB
- Exchange NASDAQ
- Sector Healthcare
- Industry Biotechnology
- Shares Outstandng 17,946,000
- Market Cap $43.4M
- Description
- INmune Bio, Inc., a clinical-stage immunotherapy company, focuses on developing drugs to reprogram the patient's innate immune system to treat disease. The company develops and commercializes product candidates to treat hematologic malignancies, solid tumors, and chronic inflammation. Its development programs include INKmune, which focuses on tr...